Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 436

Winnow Fund wins over limited partners

The fund will back student-founded startups in Wisconsin under the management of a former member of UW-Madison's Office of Industrial Partnerships.

Sep 18, 2020

Sui switches Arkansas for Virginia Tech

University of Arkansas's vice-chancellor or research and innovation will depart this winter to be replaced by John English, dean of the College of Engineering.

Sep 18, 2020

Winnow Fund wins over corporate LPs

MGE Energy, Capital Times and Johnsonville Ventures all contributed to the $6m first close of the Wisconsin student-focused venture fund.

Sep 18, 2020

Ready gets $54m response to 2020 growth

GV participated in a round that increased the on-demand healthcare service's overall funding to $107m, with the cash to go to expanding its operations.

Sep 18, 2020

Palleon packs $100m into series B

SR One, AbbVie Ventures, Takeda Ventures and Pfizer Ventures all returned for the cancer and inflammatory disease drug developer's series B.

Sep 18, 2020

PWNHealth sees Blue with series A round

Blue Venture Fund took part in a $61.8m round for the testing services provider, and managing director Anna Haghgooie will join PWNHealth’s board.

Sep 18, 2020

McKesson Ventures makes two new partners

Carrie Hurwitz Williams has been promoted from principal while Jennifer Carter will add the role to her vice-president of portfolio development, marketing and venture operations position.

Sep 18, 2020

Daily deal net: September 17, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Sep 17, 2020

Seegrid reframes latest round to $52m

CMU's warehouse vehicle manufacturer Seegrid has more than doubled its latest round to $52m, building on an initial $25m from G2VP six months ago.

Sep 17, 2020

Graphite Bio fleshes out $45m series A

Graphite Bio's first drug program will target sickle cell anaemia based on innovations in DNA editing from Stanford University.

Sep 17, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here